Aromatase Inhibitors in the Treatment of Severe Endometriosis
Letrozole relieved endometriosis-associated pain in a postmenopausal woman when exemestane failed, indicating differential patient response to aromatase inhibitors.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This case report examines the efficacy of aromatase inhibitors for managing severe endometriosis-associated chronic pelvic pain in a postmenopausal woman who remained symptomatic after hysterectomy and bilateral salpingo-oophorectomy. The patient initially failed to respond to exemestane but experienced significant pain relief with letrozole, while concomitant estrogen therapy successfully managed hot flushes without triggering pain recurrence. The authors conclude that letrozole was superior to exemestane in this instance, highlighting that patients may exhibit variable responses to different agents within the same drug class. This paper is centrally about endometriosis — specifically the pharmacological management of persistent pelvic pain following surgical menopause when standard hormonal suppression has failed.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
1,057 characters
· extracted from
oa-doi-fallback
· 2 sections
· click to expand
Background
Conclusion
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (23)
- A life shaped by pain: women and endometriosis via openalex
- A review of current management of endometriosis in 2006: an evidence-based approach. via openalex
- Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis via openalex
- Aromatase inhibitors: the next generation of therapeutics for endometriosis? via openalex
- Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients via openalex
- Correlation between endometriosis and pelvic pain via openalex
- Diagnosis and management of endometriosis. via openalex
- Long-term Effectiveness of Presacral Neurectomy for the Treatment of Severe Dysmenorrhea Due to Endometriosis via openalex
- Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome via openalex
- Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor via openalex
- The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2-5 year follow-up via openalex
- Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain via openalex
- W2129015561 via openalex
- W2028404121 via openalex
- W2015807835 via openalex
- W2159803441 via openalex
- W1969234722 via openalex
- W2403858309 via openalex
- W4236627566 via openalex
- W6601720227 via openalex
- W2049810240 via openalex
- W6608139517 via openalex
- W2046794494 via openalex
Cited by (45)
- Bladder Endometriosis: What do we know and what is left to find out? A narrative review 2024
- A Systematic Review of Systematic Reviews on the Use of Aromatase Inhibitors for the Treatment of Endometriosis: The Evidence to Date 2023
- Clues for Improving the Pathophysiology Knowledge for Endometriosis Using Plasma Micro-RNA Expression 2022
- Uso de inhibidores de la aromatasa en el tratamiento del dolor pélvico asociado a endometriosis: revisión sistemática 2021
- Use of aromatase inhibitors in menopausal deep endometriosis: a case report and literature review 2021
- Uso de inhibidores de la aromatasa en el tratamiento del dolor pélvico asociado a endometriosis: revisión sistemática 2021
- Evaluation of the effect of aromatase inhibitor in reducing the size of endometrioma 2021
- Pelvic Pain 2020
- Aromatase Inhibitors Use for Endometriosis Patients 2020
- Postmenopausal endometriosis, where are we now? 2019
- Human Reproduction: From State of the Art to Future Developments “Endometriosis Therapeutic Approaches” 2018
- Localisations urinaires de l’endométriose. Résultats et modalités techniques de la prise en charge chirurgicale. RPC Endométriose CNGOF-HAS 2018
- Infertilidade na endometriose: etiologia e terapêutica 2018
- New developments in the medical treatment of endometriosis 2017
- Huge Retroperitoneal Endometriotic Mass Adherent to the Sheaths of the Great Pelvic Vessels: 10 Years After Panhysterectomy (Parasitic Endometriosis) 2017
- Implications of immune dysfunction on endometriosis associated infertility 2016
- Aromatase inhibitors in the treatment of endometriosis 2016
- Effects of cisplatin and letrozole on surgically induced endometriosis and comparison of the two medications in a rat model 2016
- Endometriosis after Menopause 2015
- Emerging treatment of endometriosis 2015
- Use of aromatase inhibitors in practice of gynecology 2015
- Emerging therapy for endometriosis 2015
- Impact of Medical and Surgical Treatment of Endometriosis on the Cure of Endometriosis and Pain 2014
- The Concept of Endometriosis as Chronic Disease: Surgical and Medical Therapy with Hormonal and Nonhormonal Targets and the Influence of Endometriosis on Obstetrical Outcome 2014
- Role of Aromatase Inhibitors in the Treatment of Endometriosis 2014
- Potential role of aromatase inhibitors in the treatment of endometriosis 2014
- Chronic Abdominal Pain of Gynecologic Causes: Diagnosis and Treatment 2014
- Aromatase inhibitors for the treatment of endometriosis 2012
- Aromatase inhibitors in post-menopausal endometriosis 2011
- The emerging use of aromatase inhibitors for endometriosis treatment 2011
- Lymphatic spread of endometriosis to pelvic sentinel lymph nodes: a prospective clinical study 2011
- Evidence-based long-term management of endometriosis: Medical therapy and treatment of infertility 2011
- Are aromatase inhibitors effective in endometriosis treatment? 2011
- Post-menopausal endometriosis with inferior vena cava invasion requiring surgical management 2011
- Expression of aromatase in endometiosis and its relation to clinical laboratory and surgical parameters 2010
- Use of aromatase inhibitors in gynecology 2010
- Traitement de l’endométriose par les inhibiteurs de l’aromatase : efficacité thérapeutique et conséquences osseuses 2010
- Aromatase Inhibitors: Potential Reproductive Implications 2009
- Pharmacological Treatment of Endometriosis 2009
- Hormone therapy for endometriosis and surgical menopause 2009
- Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis 2009
- Decreased expression of aromatase in the Ishikawa and RL95-2 cells by the isoflavone, puerarin, is associated with inhibition of c-jun expression and AP-1 activity 2008
- New drugs in development for the treatment of endometriosis 2008
- Treatment strategies for endometriosis 2008
- Emerging drugs for endometriosis 2008
Source provenance
- europepmc
- last seen: 2026-09-21T06:08:07.822426+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:14:54.534439+00:00
- unpaywall
- last seen: 2026-09-23T06:15:37.550144+00:00